Skip to main content

Katherine Atkinson

Epic Science has appointed Katherine Atkinson as chief commercial officer, tasked with the development of Epic's global commercial strategy.

Atkinson joins Epic with two decades of life science and healthcare experience, most recently as vice president of business development at Edico Genome. Prior to Edico, Atkinson worked for Illumina, where she oversaw a variety of sales teams. She has also held positions at Fisher Scientific, Thermo Fisher, and Beckman Coulter.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.